AI Assistant
Blog
Pricing
Log In
Sign Up
DOP034. Comparative effectiveness of infliximab and adalimumab in Crohn’s disease: results from a real-life population-based cohort
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.